One of SMC Hospitals
Specialized Medical Co. (SMC) received SAR 200 million from the selling shareholders, as part of the recently completed initial public offering (IPO), and in accordance with the supplementary prospectus issued for the offering. 
SMC, recently listed on the Main Market (TASI), said the positive financial impact of this return will appear in its financial statements for Q2 2025.
For more news on listed companies
In a statement to Tadawul today, June 30, the company noted that this disclosure is part of the ongoing updates outlined in the supplementary prospectus.
According to data available with Argaam, the supplementary prospectus reflected a revision to the dividend distribution schedule for previous periods. The general assembly, held on May 22, approved the cancellation of SAR 200 million in dividend distributions to current shareholders, returning the amount to the company. This will be accounted for in Q2 2025 financial results.
One of SMC Hospitals
Specialized Medical Co. (SMC) received SAR 200 million from the selling shareholders, as part of the recently completed initial public offering (IPO), and in accordance with the supplementary prospectus issued for the offering.
SMC, recently listed on the Main Market (TASI), said the positive financial impact of this return will appear in its financial statements for Q2 2025.
For more news on listed companies
In a statement to Tadawul today, June 30, the company noted that this disclosure is part of the ongoing updates outlined in the supplementary prospectus.
According to data available with Argaam, the supplementary prospectus reflected a revision to the dividend distribution schedule for previous periods. The general assembly, held on May 22, approved the cancellation of SAR 200 million in dividend distributions to current shareholders, returning the amount to the company. This will be accounted for in Q2 2025 financial results.
